1. 50 years or older <br/ >2. Both male and female subjects will be included <br/ >3. Positive oropharyngeal/nasal swab RT-PCR for Sars-Co-V2. Diagnosed not more than 2 days ago (diagnosis �2days). <br/ >4. Either asymptomatic or have mild symptoms. Onset of symptoms within no more than 4 days If symptomatic, symptoms are mild (cough, weakness, sore throat, low grade fever 38.50С, respiratory rate should not be more than 22 / min, resting SpO2 >95%, normal highly sensitive C-reactive protein (HS-CRP) ( <10mg/L). There are no signs of dehydration, sepsis or shortness of breath. <br/ >5. Chronic stable medical conditions: diabetes mellitus, or hypertension, or chronic heart disease. Under treatment and controlled by medication <br/ >6. Signed informed consent/or consent given through text message, WhatsApp or e-mail. <br/ >7. Ability to understand the requirements of the Research Protocol and follow the research procedures. <br/ >8. Subject should be willing to be managed in isolation wards <br/ >9. Negative pregnancy test (for female participants) <br/ >10. Adequate contraception for study duration <br/ >

1. 50 years or older <br/ >2. Both male and female subjects will be included <br/ >3. Positive oropharyngeal/nasal swab RT-PCR for Sars-Co-V2. Diagnosed not more than 2 days ago (diagnosis �2days). <br/ >4. Either asymptomatic or have mild symptoms. Onset of symptoms within no more than 4 days If symptomatic, symptoms are mild (cough, weakness, sore throat, low grade fever 38.50С, respiratory rate should not be more than 22 / min, resting SpO2 >95%, normal highly sensitive C-reactive protein (HS-CRP) ( <10mg/L). There are no signs of dehydration, sepsis or shortness of breath. <br/ >5. Chronic stable medical conditions: diabetes mellitus, or hypertension, or chronic heart disease. Under treatment and controlled by medication <br/ >6. Signed informed consent/or consent given through text message, WhatsApp or e-mail. <br/ >7. Ability to understand the requirements of the Research Protocol and follow the research procedures. <br/ >8. Subject should be willing to be managed in isolation wards <br/ >9. Negative pregnancy test (for female participants) <br/ >10. Adequate contraception for study duration <br/ >

1. 50 years or older <br/ >2. Both male and female subjects will be included <br/ >3. Positive oropharyngeal/nasal swab RT-PCR for Sars-Co-V2. Diagnosed not more than 2 days ago (diagnosis �2days). <br/ >4. Either asymptomatic or have mild symptoms. Onset of symptoms within no more than 4 days If symptomatic, symptoms are mild (cough, weakness, sore throat, low grade fever 38.50С, respiratory rate should not be more than 22 / min, resting SpO2 >95%, normal highly sensitive C-reactive protein (HS-CRP) ( <10mg/L). There are no signs of dehydration, sepsis or shortness of breath. <br/ >5. Chronic stable medical conditions: diabetes mellitus, or hypertension, or chronic heart disease. Under treatment and controlled by medication <br/ >6. Signed informed consent/or consent given through text message, WhatsApp or e-mail. <br/ >7. Ability to understand the requirements of the Research Protocol and follow the research procedures. <br/ >8. Subject should be willing to be managed in isolation wards <br/ >9. Negative pregnancy test (for female participants) <br/ >10. Adequate contraception for study duration <br/ >

1. 50 years or older <br/ >2. Both male and female subjects will be included <br/ >3. Positive oropharyngeal/nasal swab RT-PCR for Sars-Co-V2. Diagnosed not more than 2 days ago (diagnosis �2days). <br/ >4. Either asymptomatic or have mild symptoms. Onset of symptoms within no more than 4 days If symptomatic, symptoms are mild (cough, weakness, sore throat, low grade fever 38.50С, respiratory rate should not be more than 22 / min, resting SpO2 >95%, normal highly sensitive C-reactive protein (HS-CRP) ( <10mg/L). There are no signs of dehydration, sepsis or shortness of breath. <br/ >5. Chronic stable medical conditions: diabetes mellitus, or hypertension, or chronic heart disease. Under treatment and controlled by medication <br/ >6. Signed informed consent/or consent given through text message, WhatsApp or e-mail. <br/ >7. Ability to understand the requirements of the Research Protocol and follow the research procedures. <br/ >8. Subject should be willing to be managed in isolation wards <br/ >9. Negative pregnancy test (for female participants) <br/ >10. Adequate contraception for study duration <br/ >